The global Biological Safety Testing market is projected to grow at a CAGR of 12.6% by 2034
The Biological Safety Testing Market Report 2024-2034: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.
Heightened Data Security and Privacy Concerns Hampering Market Growth
The exponential growth in data volume within the biopharmaceutical sector has intensified the imperative of ensuring data security and privacy, presenting a significant restraint in the biological safety testing market. As biopharmaceutical businesses amass vast quantities of information encompassing patient data, research findings, and regulatory compliance records, they become increasingly susceptible to malicious activities perpetrated by both criminal entities and state-sponsored actors.
Of particular concern is the vulnerability of personal health information (PHI), which, if compromised, can fuel a myriad of nefarious activities including financial and medical fraud, identity theft, and intelligence gathering for malicious purposes. Compounding this threat is the clandestine nature of breaches involving PHI, often evading detection for extended periods, thus amplifying the potential impact on individuals and organizations alike.
Moreover, the advent of sophisticated AI-driven systems introduces novel risks, as attackers may exploit vulnerabilities to undermine the integrity of underlying AI models through data poisoning attacks. Additionally, the theft of intellectual property via model stealing techniques poses a formidable challenge, further exacerbating concerns surrounding data security and privacy in the biological safety testing market.
Against a backdrop of heightened cybersecurity threats and intensified regulatory scrutiny, companies operating in the biological safety testing market face formidable challenges in safeguarding sensitive data generated throughout testing processes. The imperative of ensuring data security and privacy not only demands robust technological safeguards but also necessitates comprehensive risk management strategies and proactive compliance initiatives to mitigate potential vulnerabilities and safeguard the integrity of critical data assets. Failure to address these challenges adequately may impede market growth and erode stakeholder trust, underscoring the urgency for concerted efforts to fortify data security and privacy measures within the biological safety testing industry.
What Questions Should You Ask before Buying a Market Research Report?
How is the biological safety testing market evolving?
What is driving and restraining the biological safety testing market?
How will each biological safety testing submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2034?
How will the market shares for each biological safety testing submarket develop from 2024 to 2034?
What will be the main driver for the overall market from 2024 to 2034?
Will leading biological safety testing markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
How will the market shares of the national markets change by 2034 and which geographical region will lead the market in 2034?
Who are the leading players and what are their prospects over the forecast period?
What are the biological safety testing projects for these leading companies?
How will the industry evolve during the period between 2024 and 2034? What are the implications of biological safety testing projects taking place now and over the next 10 years?
Is there a greater need for product commercialisation to further scale the Biological Safety Testing market?
Where is the biological safety testing market heading and how can you ensure you are at the forefront of the market?
What are the best investment options for new product and service lines?
What are the key prospects for moving companies into a new growth path and C-suite?
You need to discover how this will impact the Biological Safety Testing market today, and over the next 10 years:
Our 299-page report provides 99 tables and 177 charts/graphs exclusively to you.
The report highlights key lucrative areas in the industry so you can target them - NOW.
It contains in-depth analysis of global, regional and national sales and growth.
It highlights for you the key successful trends, changes and revenue projections made by your competitors.
Forecasts to 2034 and other analyses reveal commercial prospects
In addition to revenue forecasting to 2034, our new study provides you with recent results, growth rates, and market shares.
You will find original analyses, with business outlooks and developments.
Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), Porter's Five Forces Analysis, PEST Analysis and recent developments.
Segments Covered in the Report
Product
Consumables
Instruments
Services & Others
Application Outlook
Cellular & Gene Therapy
Monoclonal Antibodies (mAbs)
Vaccines & Therapeutics
Blood-based Therapy & Others
Tests Outlook
Endotoxin Tests
Mycoplasma Tests
Sterility Tests
Residual Host Contamination Detection Tests
Bioburden Tests
Virus Safety Tests
Others
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 20 leading national markets:
North America
U.S.
Canada
Europe
Germany
UK
France
Spain
Italy
Rest of Europe
Asia Pacific
China
Japan
India
Australia
South Korea
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
MEA
GCC
South Africa
Rest of MEA
The report also includes profiles for some of the leading companies in the Biological Safety Testing Market, 2024 to 2034, with a focus on this segment of these companies' operations.
Leading companies profiled in the report
Almac Group
Charles River Laboratories
Clean Cells
Creative Biogene
Eurofins Scientific
F. Hoffmann-La Roche Ltd.
Laboratory Corporation of America
Lonza Group
Merck KGaA
Sartorius AG
SGS Societe Generale de Surveillance SA
Thermo Fisher Scientific Inc.
Wuxi Apptec
Overall world revenue for Biological Safety Testing Market, 2024 to 2034 in terms of value the market will surpass US$3,900 million in 2024, our work calculates. We predict strong revenue growth through to 2034. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How will the Biological Safety Testing Market, 2024 to 2034 report help you?
In summary, our 290+ page report provides you with the following knowledge:
Revenue forecasts to 2034 for Biological Safety Testing Market, 2024 to 2034 Market, with forecasts for product, application, and tests, each forecast at a global and regional level - discover the industry's prospects, finding the most lucrative places for investments and revenues.
Revenue forecasts to 2034 for five regional and 20 key national markets - See forecasts for the Biological Safety Testing Market, 2024 to 2034 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
Prospects for established firms and those seeking to enter the market - including company profiles for 10 of the major companies involved in the Biological Safety Testing Market, 2024 to 2034.
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.
Information found nowhere else
With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain's study is for everybody needing commercial analyses for the Biological Safety Testing Market, 2024 to 2034, market-leading companies. You will find data, trends and predictions.
Table of Contents
1 Report Overview
- 1.1 Objectives of the Study
- 1.2 Introduction to Biological Safety Testing Market
- 1.3 What This Report Delivers
- 1.4 Why You Should Read This Report
- 1.5 Key Questions Answered by This Analytical Report
- 1.6 Who is This Report for?
- 1.7 Methodology
- 1.7.1 Market Definitions
- 1.7.2 Market Evaluation & Forecasting Methodology
- 1.7.3 Data Validation
- 1.7.3.1 Primary Research
- 1.7.3.2 Secondary Research
- 1.8 Frequently Asked Questions (FAQs)
- 1.9 Associated Visiongain Reports
- 1.10 About Visiongain
2 Executive Summary
3 Market Overview
- 3.1 Key Findings
- 3.2 Market Dynamics
- 3.3 Impact Analysis
- 3.3.1 Market Driving Factors
- 3.3.1.1 Biologics Boom is Fuelling the Demand for Safety Testing
- 3.3.1.2 Increasing Pharma Investments to Boost the Biologics Safety Testing Market Demand
- 3.3.1.3 Biotech Investment Surge Propels Global Biological Safety Testing Market
- 3.3.1.4 Multinational Leaders Drive Biologics Safety Testing Market Expansion through Strategic Investments and Collaborations
- 3.3.2 Market Restraining Factors
- 3.3.2.1 Navigating Challenges in Biologic Safety Testing - A Complex Landscape
- 3.3.2.2 Heightened Data Security and Privacy Concerns
- 3.3.3 Market Opportunities
- 3.3.3.1 Digital Tech and AI to Transform the Biological Safety Testing Market
- 3.3.3.2 Increasing Demand for Generics and Biosimilars to act as Catalyst for the market Growth
- 3.4 Supply Chain Analysis
- 3.5 Regulatory Framework
- 3.6 Emerging Markets and Megatrends
- 3.7 Porter's Five Forces Analysis
- 3.7.1 Bargaining Power of Suppliers
- 3.7.2 Bargaining Power of Buyers
- 3.7.3 Competitive Rivalry
- 3.7.4 Threat of Substitutes
- 3.7.5 Threat of New Entrants
- 3.8 PEST Analysis
4 Biological Safety Testing Market Analysis by Products
- 4.1 Key Findings
- 4.2 Products Segment: Market Attractiveness Index
- 4.3 Biological Safety Testing Market Size Estimation and Forecast by Products
- 4.4 Consumables
- 4.4.1 Market Size by Region, 2024-2034 (US$ Million)
- 4.4.2 Market Share by Region, 2024 & 2034 (%)
- 4.5 Instruments
- 4.5.1 Market Size by Region, 2024-2034 (US$ Million)
- 4.5.2 Market Share by Region, 2024 & 2034 (%)
- 4.6 Service & Others
- 4.6.1 Market Size by Region, 2024-2034 (US$ Million)
- 4.6.2 Market Share by Region, 2024 & 2034 (%)
5 Biological Safety Testing Market Analysis by Application
- 5.1 Key Findings
- 5.2 Application Segment: Market Attractiveness Index
- 5.3 Biological Safety Testing Market Size Estimation and Forecast by Application
- 5.4 Cellular & Gene Therapy
- 5.4.1 Market Size by Region, 2024-2034 (US$ Million)
- 5.4.2 Market Share by Region, 2024 & 2034 (%)
- 5.5 Monoclonal Antibodies (mAbs)
- 5.5.1 Market Size by Region, 2024-2034 (US$ Million)
- 5.5.2 Market Share by Region, 2024 & 2034 (%)
- 5.6 Vaccines & Therapeutics
- 5.6.1 Market Size by Region, 2024-2034 (US$ Million)
- 5.6.2 Market Share by Region, 2024 & 2034 (%)
- 5.7 Blood-based Therapy & Others
- 5.7.1 Market Size by Region, 2024-2034 (US$ Million)
- 5.7.2 Market Share by Region, 2024 & 2034 (%)
6 Biological Safety Testing Market Analysis by Test
- 6.1 Key Findings
- 6.2 Test Segment: Market Attractiveness Index
- 6.3 Biological Safety Testing Market Size Estimation and Forecast by Test
- 6.4 Endotoxin Tests
- 6.4.1 Market Size by Region, 2024-2034 (US$ Million)
- 6.4.2 Market Share by Region, 2024 & 2034 (%)
- 6.5 Mycoplasma Tests
- 6.5.1 Market Size by Region, 2024-2034 (US$ Million)
- 6.5.2 Market Share by Region, 2024 & 2034 (%)
- 6.6 Sterility Tests
- 6.6.1 Market Size by Region, 2024-2034 (US$ Million)
- 6.6.2 Market Share by Region, 2024 & 2034 (%)
- 6.7 Residual Host Contamination Detection Tests
- 6.7.1 Market Size by Region, 2024-2034 (US$ Million)
- 6.7.2 Market Share by Region, 2024 & 2034 (%)
- 6.8 Bioburden Tests
- 6.8.1 Market Size by Region, 2024-2034 (US$ Million)
- 6.8.2 Market Share by Region, 2024 & 2034 (%)
- 6.9 Virus Safety Tests
- 6.9.1 Market Size by Region, 2024-2034 (US$ Million)
- 6.9.2 Market Share by Region, 2024 & 2034 (%)
- 6.10 Others
- 6.10.1 Market Size by Region, 2024-2034 (US$ Million)
- 6.10.2 Market Share by Region, 2024 & 2034 (%)
7 Biological Safety Testing Market Analysis by Region
- 7.1 Key Findings
- 7.2 Regional Market Size Estimation and Forecast
8 North America Biological Safety Testing Market Analysis
- 8.1 Key Findings
- 8.2 North America Biological Safety Testing Market Attractiveness Index
- 8.3 North America Biological Safety Testing Market by Country, 2024, 2029 & 2034 (US$ Million)
- 8.4 North America Biological Safety Testing Market Size Estimation and Forecast by Country
- 8.5 North America Biological Safety Testing Market Size Estimation and Forecast by Products
- 8.6 North America Biological Safety Testing Market Size Estimation and Forecast by Application
- 8.7 North America Biological Safety Testing Market Size Estimation and Forecast by Tests
- 8.8 U.S. Biological Safety Testing Market Analysis
- 8.9 Canada Biological Safety Testing Market Analysis
9 Europe Biological Safety Testing Market Analysis
- 9.1 Key Findings
- 9.2 Europe Biological Safety Testing Market Attractiveness Index
- 9.3 Europe Biological Safety Testing Market by Country, 2024, 2029 & 2034 (US$ Million)
- 9.4 Europe Biological Safety Testing Market Size Estimation and Forecast by Country
- 9.5 Europe Biological Safety Testing Market Size Estimation and Forecast by Product
- 9.6 Europe Biological Safety Testing Market Size Estimation and Forecast by Application
- 9.7 Europe Biological Safety Testing Market Size Estimation and Forecast by Tests
- 9.8 Germany Biological Safety Testing Market Analysis
- 9.9 France Biological Safety Testing Market Analysis
- 9.10 UK Biological Safety Testing Market Analysis
- 9.11 Italy Biological Safety Testing Market Analysis
- 9.12 Spain Biological Safety Testing Market Analysis
- 9.13 Rest of Europe Biological Safety Testing Market Analysis
10 Asia Pacific Biological Safety Testing Market Analysis
- 10.1 Key Findings
- 10.2 Asia Pacific Biological Safety Testing Market Attractiveness Index
- 10.3 Asia Pacific Biological Safety Testing Market by Country, 2024, 2029 & 2034 (US$ Million)
- 10.4 Asia Pacific Biological Safety Testing Market Size Estimation and Forecast by Country
- 10.5 Asia Pacific Biological Safety Testing Market Size Estimation and Forecast by Product
- 10.6 Asia Pacific Biological Safety Testing Market Size Estimation and Forecast by Application
- 10.7 Asia Pacific Biological Safety Testing Market Size Estimation and Forecast by Tests
- 10.8 Japan Biological Safety Testing Market Analysis
- 10.9 China Biological Safety Testing Market Analysis
- 10.10 India Biological Safety Testing Market Analysis
- 10.11 Australia Biological Safety Testing Market Analysis
- 10.12 South Korea Biological Safety Testing Market Analysis
- 10.13 Rest of Asia Pacific Biological Safety Testing Market Analysis
11 Latin America Biological Safety Testing Market Analysis
- 11.1 Key Findings
- 11.2 Latin America Biological Safety Testing Market Attractiveness Index
- 11.3 Latin America Biological Safety Testing Market by Country, 2024, 2029 & 2034 (US$ Million)
- 11.4 Latin America Biological Safety Testing Market Size Estimation and Forecast by Country
- 11.5 Latin America Biological Safety Testing Market Size Estimation and Forecast by Product
- 11.6 Latin America Biological Safety Testing Market Size Estimation and Forecast by Application
- 11.7 Latin America Biological Safety Testing Market Size Estimation and Forecast by Tests
- 11.8 Brazil Biological Safety Testing Market Analysis
- 11.9 Mexico Biological Safety Testing Market Analysis
- 11.10 Rest of Latin America Biological Safety Testing Market Analysis
12 MEA Biological Safety Testing Market Analysis
- 12.1 Key Findings
- 12.2 MEA Biological Safety Testing Market Attractiveness Index
- 12.3 MEA Biological Safety Testing Market by Country, 2024, 2029 & 2034 (US$ Million)
- 12.4 MEA Biological Safety Testing Market Size Estimation and Forecast by Country
- 12.5 MEA Biological Safety Testing Market Size Estimation and Forecast by Product
- 12.6 MEA Biological Safety Testing Market Size Estimation and Forecast by Application
- 12.7 MEA Biological Safety Testing Market Size Estimation and Forecast by Tests
- 12.8 GCC Biological Safety Testing Market Analysis
- 12.9 South Africa Biological Safety Testing Market Analysis
- 12.10 Rest of MEA Biological Safety Testing Market Analysis
13 Next Generation Sequencing in Biological Safety Testing Market Analysis
- 13.1 Market Overview
- 13.2 Market Dynamics Key Findings
- 13.3 Market Dynamics
- 13.4 Impact Analysis
- 13.4.1 Market Driving Factors
- 13.4.1.1 Cost-effective Rise of Next-Generation Sequencing is Revolutionizing Biological Safety Testing
- 13.4.1.2 Elevating Biological Safety Testing with Superior Sensitivity and Resolution
- 13.4.2 Market Restraining Factors
- 13.4.2.1 Integration, Scalability, and Data Interpretation
- 13.4.2.2 Key Challenges in Expanding NGS Test Menus for Biological Safety Testing
- 13.4.3 Market Opportunities
- 13.4.3.1 Long-read Sequencing to Create Incremental Market Opportunity
- 13.5 Product Segment: Market Attractiveness Index
- 13.5.1 Next Generation Sequencing in Biological Safety Testing Market Size Estimation and Forecast by Product
- 13.5.1.1 Consumables
- 13.5.1.2 Instruments
- 13.5.1.3 Services & Others
- 13.6 Sequencing Segment: Market Attractiveness Index
- 13.6.1 Next Generation Sequencing in Biological Safety Testing Market Size Estimation and Forecast by Sequencing
- 13.6.1.1 Short-read Sequencing
- 13.6.1.2 Long-read Sequencing
- 13.7 Test Segment: Market Attractiveness Index
- 13.7.1 Next Generation Sequencing in Biological Safety Testing Market Size Estimation and Forecast by Test
- 13.7.1.1 Sterility Tests
- 13.7.1.2 Mycoplasma Tests
- 13.7.1.3 Adventitious Virus Detection Tests
- 13.7.1.4 Sequence Identity Confirmation
- 13.7.1.5 Others
- 13.8 Regional Segment: Market Attractiveness Index
- 13.8.1 Next Generation Sequencing in Biological Safety Testing Market Size Estimation and Forecast by Region
- 13.8.1.1 North America
- 13.8.1.2 Europe
- 13.8.1.3 Asia Pacific
- 13.8.1.4 Latin America
- 13.8.1.5 MEA
14 Company Profiles
- 14.1 Competitive Landscape, 2023
- 14.2 Strategic Outlook
- 14.3 Charles River Laboratories
- 14.3.1 Company Snapshot
- 14.3.2 Company Overview
- 14.3.3 Financial Analysis
- 14.3.3.1 Net Revenue, 2019-2023
- 14.3.3.2 Business Segment Market Shares, 2023
- 14.3.4 Service Benchmarking
- 14.3.5 Strategic Outlook
- 14.3.6 SWOT Analysis
- 14.4 Thermo Fisher Scientific Inc.
- 14.4.1 Company Snapshot
- 14.4.2 Company Overview
- 14.4.3 Financial Analysis
- 14.4.3.1 Net Revenue, 2019-2023
- 14.4.3.2 R&D, 2019-2023
- 14.4.3.3 Regional Market Shares, 2023
- 14.4.3.4 Business Segment Market Shares, 2023
- 14.4.4 Service Benchmarking
- 14.4.5 Strategic Outlook
- 14.4.6 SWOT Analysis
- 14.5 Merck KGaA
- 14.5.1 Company Snapshot
- 14.5.2 Company Overview
- 14.5.3 Financial Analysis
- 14.5.3.1 Net Revenue, 2019-2023
- 14.5.3.2 R&D, 2019-2023
- 14.5.3.3 Regional Market Shares, 2023
- 14.5.3.4 Business Segment Market Shares, 2023
- 14.5.4 Service Benchmarking
- 14.5.5 Strategic Outlook
- 14.5.6 SWOT Analysis
- 14.6 F. Hoffmann-La Roche Ltd.
- 14.6.1 Company Snapshot
- 14.6.2 Company Overview
- 14.6.3 Financial Analysis
- 14.6.3.1 Net Revenue, 2019-2023
- 14.6.3.2 R&D, 2019-2023
- 14.6.3.3 Regional Market Shares, 2023
- 14.6.3.4 Business Segment Market Shares, 2023
- 14.6.4 Service Benchmarking
- 14.7 Lonza Group
- 14.7.1 Company Snapshot
- 14.7.2 Company Overview
- 14.7.3 Financial Analysis
- 14.7.3.1 Net Revenue, 2019-2023
- 14.7.3.2 R&D, 2019-2023
- 14.7.3.3 Regional Market Shares, 2023
- 14.7.3.4 Business Segment Market Shares, 2023
- 14.7.4 Service Benchmarking
- 14.7.5 Strategic Outlook
- 14.8 Laboratory Corporation of America
- 14.8.1 Company Snapshot
- 14.8.2 Company Overview
- 14.8.3 Financial Analysis
- 14.8.3.1 Net Revenue, 2019-2023
- 14.8.3.2 Regional Market Shares, 2023
- 14.8.3.3 Business Segment Market Shares, 2023
- 14.8.4 Service Benchmarking
- 14.8.5 Strategic Outlook
- 14.9 Eurofins Scientific
- 14.9.1 Company Snapshot
- 14.9.2 Company Overview
- 14.9.3 Financial Analysis
- 14.9.3.1 Net Revenue, 2019-2023
- 14.9.3.2 Regional Market Shares, 2023
- 14.9.4 Service Benchmarking
- 14.9.5 Strategic Outlook
- 14.10 SGS Societe Generale de Surveillance SA
- 14.10.1 Company Snapshot
- 14.10.2 Company Overview
- 14.10.3 Financial Analysis
- 14.10.3.1 Net Revenue, 2019-2023
- 14.10.3.2 Regional Market Shares, 2023
- 14.10.4 Service Benchmarking
- 14.10.5 Strategic Outlook
- 14.11 Sartorius AG
- 14.11.1 Company Snapshot
- 14.11.2 Company Overview
- 14.11.3 Financial Analysis
- 14.11.3.1 Net Revenue, 2019-2023
- 14.11.3.2 R&D, 2019-2023
- 14.11.3.3 Regional Market Shares, 2023
- 14.11.3.4 Business Segment Market Shares, 2023
- 14.11.4 Service Benchmarking
- 14.12 WuXi AppTec
- 14.12.1 Company Snapshot
- 14.12.2 Company Overview
- 14.12.3 Financial Analysis
- 14.12.3.1 Net Revenue, 2019-2023
- 14.12.3.2 R&D, 2019-2023
- 14.12.3.3 Regional Market Shares, 2023
- 14.12.3.4 Business Segment Market Shares, 2023
- 14.12.4 Service Benchmarking
- 14.13 Almac Group
- 14.13.1 Company Snapshot
- 14.13.2 Company Overview
- 14.13.3 Service Benchmarking
- 14.13.4 Strategic Outlook
- 14.14 Clean Cells
- 14.14.1 Company Snapshot
- 14.14.2 Company Overview
- 14.14.3 Service Benchmarking
- 14.14.4 Strategic Outlook
- 14.15 Creative Biogene
- 14.15.1 Company Snapshot
- 14.15.2 Company Overview
- 14.15.3 Service Benchmarking
15 Conclusion and Recommendations
- 15.1 Concluding Remarks from Visiongain
- 15.2 Recommendations for Market Players
